VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10016040 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10012545 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10011001 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10012546 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10007207 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10026202 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10034297 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10020768 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10020855 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
TVIS10047896 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CACNB2 |
---|---|
DrugBank ID | DB06712 |
Drug Name | Nilvadipine |
Target ID | BE0002354 |
UniProt ID | Q08289 |
Regulation Type | inhibitor |
PubMed IDs | 7898101; 1283184; 20933604 |
Citations | Rosenthal J: Nilvadipine: profile of a new calcium antagonist. An overview. J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107.@@Honerjager P, Seibel K: Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist. J Cardiovasc Pharmacol. 1992;20 Suppl 6:S15-21.@@Araie M, Mayama C: Use of calcium channel blockers for glaucoma. Prog Retin Eye Res. 2011 Jan;30(1):54-71. doi: 10.1016/j.preteyeres.2010.09.002. Epub 2010 Oct 8. |
Groups | Approved; Investigational |
Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
SMILES | COC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N |
Pathways | |
PharmGKB | PA165958385 |
ChEMBL | CHEMBL517427 |